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The immunologic abnormalities in patients with 
allergic skin diseases occur as a consequence of pri-
mary defects residing within the epidermis, suggest-
ing an association between skin barrier dysfunction 
and immune abnormalities (1). The skin barrier is 
located in the uppermost layers of the epidermis, 
the stratum corneum, with important elements: in-
tracellular keratin filaments, intercellular lipids, and 
a cornified cell envelope. It plays a vital role in all ter-
restrial forms of life, due to prevention of fluid loss 
and protection from microbial and allergen invasion. 
Functional lack of epidermal enzymes and structural 
skin proteins compromises skin barrier integrity and 
function. These deficiencies can even induce local 
changes in the expression of various inflammatory 
mediators, suggesting the direct immunologic role 
of the epidermis in the pathogenesis of allergic skin 
diseases (1). Primary isolated epidermal defects can 
result in allergy. Filaggrin (FLG), involucrin, and lo-
ricrin are among the most important structural pro-
teins. Also, lipids play very important role, as well as 
some enzymes, such as serine proteases. Netherton 
syndrome is classic example of autosomal recessive 
disorder due to loss-of-function mutations in SPINK5, 
the gene encoding the SP inhibitor lymphoepithelial 
Kazal-type trypsin inhibitor (LEKTI) (2). Most impor-
tantly, mutations of filaggrin (FLG) gene, an essential 
component of the skin barrier, are associated with 
ichthyosis vulgaris and atopic dermatitis (AD). AD is 
inflammatory skin disease caused by inherited skin 
barrier deficiency, with mutations in FLG predispos-
ing to development of AD. AD has highly heritable 
complex trait; however, environmental influences 
also play a role in triggering the atopic diathesis (3,4). 
Genome-wide association studies in AD have identi-
fied several susceptibility loci; however, the major and 
only functionally characterized genetic factor is FLG, 
which encodes skin barrier protein FLG (4). FLG is one 
of the most prominent genes responsible for barrier 
defect. FLG has been identified as a major locus caus-
ing skin barrier deficiency; however, not all patients 
with AD have this mutation, so AD cannot be ex-
plained by FLG mutation (3,4). Support for barrier de-
ficiency initiating AD came from flaky tail mice, which 
have frameshift mutation in FLG and also carry an 
unknown gene, the Matt gene, causing a matted hair 
phenotype (1,4,5). This phenotype in flaky tail mice is 
due to a mutation in the Tmem79/Matt gene, with no 
expression of the encoded protein mattrin in the skin 
of mutant mice. Sasaki et al. and Saunders et al. re-
port successful delineation of the genetic basis of the 
flaky tail mouse phenotype (1,4,5). Flaky tail mice dis-
play a matted hair phenotype and have spontaneous 
dermatitis under pathogen-free conditions; and have 
been used over the years as a model for AD (1). These 
mice arose spontaneously as the result of crosses 
between mice carrying a recessive mutation named 
matted (ma), and have been since maintained as 
double mutants (maft) (1). It has recently been found 
that flaky tail mice carry a deletion in the mouse FLG 
gene, suggesting that FLG deficiency might explain 
their propensity to have dermatitis, analogous with 
the situation in some human patients with AD (not 
all patients with AD have FLG mutation). Genetically 
engineered FLG-deficient mice display impaired bar-
rier function, but lack the propensity of spontane-
ous skin inflammation of flaky tail mice. Matted mice 
spontaneously develop dermatitis and atopy caused 
by a defective skin barrier, with mutant mice having 
systemic sensitization after cutaneous challenge with 
house dust mite allergens. The matted phenotype 
was found to be due to a loss-of-function mutation 
in Tmem79 (4,5). Unexpectedly, the Tmem79 muta-
tion, rather than the deletion in FLG, was found to 
be associated with the development of dermatitis in 
mice (1). Moreover, exogenous Tmem79 expression 
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was able to rescue both the hair and the dermatitis 
phenotype in flaky tail mice (1). These studies have 
elucidated the relative contributions of the FLG and 
Matt mutations in DM mice (1). These data indicate 
that the DM mouse is not a true model of FLG defi-
ciency-associated AD-like skin (3). Tmem79 is mainly 
expressed in the granular layers of the epidermis, 
where its absence correlates with abnormal function 
of lamellar granules (1,5). Those lamellar granules are 
Golgi-derived specialized organelles, responsible for 
transferring lipids and proteases to the upper part of 
the epidermis (5). Therefore, Mattrin could be a link 
between protein and lipid interaction in etiopatholo-
gy of AD. Meta-analysis of 4.245 AD cases and 10.558 
population-matched control patients showed that a 
missense SNP, rs6694514, in the human Matt gene 
has a small but significant association with AD (3). 
Expression quantitative trait locus analysis showed 
that Matt is in a network of proteins expressed late in 
epidermal differentiation, with an expression quanti-
tative trait locus profile closely matching that of Rhbg 
(transporter protein) and Rab25 (membrane traffick-
ing) (4). Mattrin shows distant sequence homology 
to the membrane- associated proteins in eicosanoid 
and glutathione metabolism (MAPEG) protein family 
(4). Matt mutation results in defective expression of 
the transmembrane protein mattrin, which is highly 
expressed in the upper granular layer of epidermal 
keratinocytes, with a predicted role in lipid homeo-
stasis. It is interesting to mention that authors noted 
that FLG mutation has a neonatal influence, whereas 
Matt mutation shows progressive influence with age. 
This indicates the polygenic nature of the DM mouse 
as an AD model and indicates the differential influ-
ence of both the FLG and Matt mutations (4). 
Recently, four new susceptibility loci for AD were 
identified and previous associations were replicated, 
which brings the number of AD-risk loci reported in 
individuals of European ancestry to 11 (7). It is esti-
mated that together, these susceptibility loci account 
for 14.4% of the heritability for AD (7). Genome-wide 
association studies (GWAS) have shown remarkable 
overlap across immune-mediated diseases (7). Two 
European GWAS on AD established four susceptibil-
ity loci (C11orf30, OVOL1, ACTL9 and RAD50-IL13-
KIF3A) in addition to FLG (4-6). At C11orf30, the same 
allele also confers risk to asthma and Crohn’s disease 
(5,9-11). For RAD50-IL13, locus agonistic effects were 
observed for asthma, and locus antagonistic effects 
were observed for psoriasis (6,12,13). Two further loci 
were reported in a Chinese GWAS (TNFRSF6B-ZGPAT 
and TMEM232-SLC25A46) (14). All loci were confirmed 
in a recent Japanese GWAS, which additionally re-
ported eight new loci (IL1RL1-IL18R1-IL18RAP, MHC, 
OR10A3-NLRP10, GLB1, CCDC80, CARD11, ZNF365, 
and CYP24A1-PFDN4) (15). However, the causal vari-
ants at all loci except FLG are unknown (6). 
In conclusion, we can state that FLG has been, and 
still remains the major susceptibility gene in patients 
with AD, but genetic pathways in atopic patients are 
complex and influenced by the environment, includ-
ing multiple genes involved in skin barrier, as well 
as proteins, lipids, and enyzmes interacting with im-
mune system. Therefore, we have many future lessons 
to learn from the genetics of atopic diseases. 
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